The Pharmacogenetics and Pharmacodynamics of Clopidogrel Response-Reference-Cited by-同舟云学术

The Pharmacogenetics and Pharmacodynamics of Clopidogrel Response

Published:2008-12 Issue:6 Volume:1 Page:620-627
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

Gladding Patrick,Webster Mark,Zeng Irene,Farrell Helen,Stewart Jim,Ruygrok Peter,Ormiston John,El-Jack Seif,Armstrong Guy,Kay Patrick,Scott Douglas,Gunes Arzu,Dahl Marja-Liisa

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference36 articles.

1. Specific impairment of human platelet P2Y(AC) ADP receptor-mediated signaling by the antiplatelet drug clopidogrel;Geiger;Arterioscler Thromb Vasc Biol,1999

2. Variability in platelet responsiveness to clopidogrel among 544 individuals;Serebruany;J Am Coll Cardiol,2005

3. Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity;Gurbel;Circulation,2003

4. Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement;Muller;Thromb Haemost,2003

5. The metabolism of clopidogrel is catalyzed by human cytochrome P450 3A and is inhibited by atorvastatin;Clarke;Drug Metab Dispos,2003

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CYP2C19 Genetic Testing for Oral P2Y12 Inhibitor Therapy: A Scientific Statement From the American Heart Association;Circulation;2024-08-06

2. Pharmacogenomic Biomarkers in Coronary Artery Disease: A Narrative Review;Biomarkers in Medicine;2024-03

3. Genotyping genetic variants of CYP2C19 for precision antiplatelet dosing: state of the art and future perspectives;Expert Opinion on Drug Metabolism & Toxicology;2022-12-02

4. Dosage optimization of clopidogrel via a precision medicine approach: the way forward;Pharmacogenomics;2022-02

5. Risk factors for adverse drug reactions associated with clopidogrel therapy;Open Medicine;2022-01-01